APA 6th Edition Harni, V., Gudelj, M., Šemnički, N. i Boras-Slivar, S. (2007). KONTRACEPTIVNI IMPLANTAT Prva iskustva. Gynaecologia et perinatologia, 16 (1), 27-32. Preuzeto s https://hrcak.srce.hr/23301
MLA 8th Edition Harni, Vesna, et al. "KONTRACEPTIVNI IMPLANTAT Prva iskustva." Gynaecologia et perinatologia, vol. 16, br. 1, 2007, str. 27-32. https://hrcak.srce.hr/23301. Citirano 27.07.2021.
Chicago 17th Edition Harni, Vesna, Maja Gudelj, Nataša Šemnički i Sanja Boras-Slivar. "KONTRACEPTIVNI IMPLANTAT Prva iskustva." Gynaecologia et perinatologia 16, br. 1 (2007): 27-32. https://hrcak.srce.hr/23301
Harvard Harni, V., et al. (2007). 'KONTRACEPTIVNI IMPLANTAT Prva iskustva', Gynaecologia et perinatologia, 16(1), str. 27-32. Preuzeto s: https://hrcak.srce.hr/23301 (Datum pristupa: 27.07.2021.)
Vancouver Harni V, Gudelj M, Šemnički N, Boras-Slivar S. KONTRACEPTIVNI IMPLANTAT Prva iskustva. Gynaecologia et perinatologia [Internet]. 2007 [pristupljeno 27.07.2021.];16(1):27-32. Dostupno na: https://hrcak.srce.hr/23301
IEEE V. Harni, M. Gudelj, N. Šemnički i S. Boras-Slivar, "KONTRACEPTIVNI IMPLANTAT Prva iskustva", Gynaecologia et perinatologia, vol.16, br. 1, str. 27-32, 2007. [Online]. Dostupno na: https://hrcak.srce.hr/23301. [Citirano: 27.07.2021.]
Sažetak Aims of the study were to determine the contraceptive effectiveness and the analysis of the pattern of ¬frequency and types of common adverse effects, the influence on menstrual bleeding and dysmenorrhoea as well as the acceptability of the idea of new contraceptive method. Material and methods. During four years of our study we ¬implanted 30 contraceptive implants with etonogestrel. After the following time the patients were asked to complete questionnairy.The data were statistically evaluated. Results. Throughout our study we followed 673 contraceptive months and registered one pregnancy. The length and the abundance of menstrual bleeding decreasead in about half of the participants. The frequency of amenorrhoea was 22.7%, whereas symptoms of dysmenorrhoea improved in all patients. As regards the most common adverse effects were vaginal bleeding disturbances, acne, weight gain and headache. ¬Implant had to be removed earlier in eight cases. Conclusion. Contraceptive implant is very effective contraceptive method. Common adverse effects, which require discontinuation of the contraception, are present in about 1/3 of users. Our recommendation however is the prescription of progestogen-only-pills with desogestrel, before the decision for ¬contraceptive implant with etonogestrel.